MIRA INFORM REPORT

 

 

Report No. :

317830

Report Date :

24.04.2015

           

IDENTIFICATION DETAILS

 

Name :

KYORITSU SEIYAKU CORPORATION

 

 

Registered Office :

GREENOAK KUDAN 2F, 1-11-5 Kudan-Kita Chiyodaku, Tokyo, 102-0073

 

 

Country :

Japan

 

 

Financials (as on) :

31.05.2015

 

 

Date of Incorporation :

May 1955

 

 

Com. Reg. No.:

0100-01-014420

 

 

Legal Form :

Not Available

 

 

Line of Business :

Subject is engaged in Import, Export, Wholesale, Manufacturer of veterinary prescription animal drugs: vaccine, vitamin, antibacterial agents, anthelmintic agents, animal feeds, pet foods, supplement.

 

 

No. of Employee :

432

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

JAPAN - ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Since the complete shutdown of Japan’s nuclear reactors after the earthquake and tsunami disaster in 2011, Japan's industrial sector has become heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession four times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. A sales tax increase caused the economy to contract during the 2nd and 3rd quarters of 2014. The economy has largely recovered in the three years since the disaster, but reconstruction in the Tohoku region has been uneven due to labor shortages. Prime Minister Shinzo ABE has declared the economy his government's top priority; he has overturned his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus, monetary easing, and structural reform. Japan joined the Trans Pacific Partnership negotiations in 2013, a pact that would open Japan's economy to increased foreign competition and create new export opportunities for Japanese businesses. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2014 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which amounts to more than 240% of GDP. To help raise government revenue and reduce public debt, Japan decided in 2013 to gradually increase the consumption tax to a total of 10% by 2015, although the government in 2014 decided to postpone the final phase of the increase until 2017 to give the economy time to recover from the 2014 increase. Japan is making progress on ending deflation due to a weaker yen and higher energy costs, but reliance on exports to drive growth and an aging, shrinking population pose other major long-term challenges for the economy.

 

Source : CIA

 

COMPANY NAME

 

KYORITSU SEIYAKU CORPORATION

Japanese company name

KYORITSU SEIYAKU KK (Kabushiki kaisha/Seiyaku means Pharmaceuticals)

 

Registered Office

1. Street Number and District

GREENOAK KUDAN 2F, 1-11-5 Kudan-Kita Chiyodaku

2. City and Perefecture

Tokyo

3. ZIP Code

102-0073

4. Country

JAPAN

*Registered at…1-5-10 Kudan-Minami Chiyodaku Tokyo

TEL

03-3263-2931

FAX

03-3230-2308

URL

www.kyoritsuseiyaku.co.jp/

Email Address

thru the URL

 

 

Activities (Services & Products)

 

Import/Export/Wholesale/Mfg of veterinary prescription animal drugs: vaccine, vitamin, antibacterial agents, anthelmintic agents, animal feeds, pet foods, suppliment, other.

 

 

 

 

 

SUMMARY OF REPORT

Annual Sales (MM YEN)

36,455

Capital Amount (MM YEN)

55

Net Worth (MM YEN)

Unavailable

FINANCES

FAIR

TREND

STEADY

EMPLOYEES

432

 

 

 

 

 

OTHER INFORMATION FOLLOWS

Year Started

1955

Month and Year Registered

May. 1955

Regd No.

0100-01-014420

Major Shareholders

1

Takaaki Takai (73%)

2

Yuhei Okamoto (14%)

3

Other

Number of Shareholders

13

Authorized Shares

280,000

Issued Shares

100,000

 

Executives

PRESIDENT

TAKAAKI TAKAI

Chairman

Yuhei Yamamoto

Vice President

Seiichi Hirano

Mgn Director

Kazuhiro Fujita

Director

Makoto Hagiwara

Director

Hidedo Ariyoshi

Main Banks

1

Mizuho Bank (Kudan)

2

SMBC (Kanda)

Relations

Satisfactory

 

Clients

1

Aesop Yakuhin

2

Morikubo Yakuhin

3

Asuko

4

Sun Daiko

5

Other

 

Suppliers

1

Toray Ind

2

Idemitsu Kosan Corporation

3

Canine Japan

4

Pet Ag

5

Other

 

Branches

1

Sapporo

2

Sendai

3

Saitama

4

Osaka

5

Other (total 11)

 

Factories

1

Saitama

2

Hiroshima

3

Tsukuba (R&D center/factory)

4

Kanagawa (distribution center/ total 3)

 

Overseas

1

None

 

 

HIGHLIGHT and COMMENT

 

The subject company is a leading trading house specializing in animal medicines, established by late Yukiko Takei's husband.  This is a specialized trader, with mfg division, for import and wholesale of veterinary drugs, all for prescription by veterinary surgeons, such as vaccine, vitamins, etc.  Also handles pulicide, antibacterial agents, anthelmintic agents, pet foods, suppliment foods, all for animals.  Animal feeds are also handled.  Nation's top-ranked wholesaler of animal drugs.  Vaccines are produced by a subsidiary maker, starting in 1969.  Have wide business tie-ups with about 20 overseas mfrs, such as Fort Dodge Animal Health, Master Foods (--USA), Inter-bet International, Abbot Laboratories, Animal Health Options, Addison Biological Laboratory, other.  In May 2009, launched production of flea/hard tick exterminator, the nation's first of such agents, and distributed in the market.  In Jun 2010, merged a subsidiary, Kawasaki Seiyaku KK, producer of pharmaceuticals for agricultural & aquatic animals, Kawasaki.  Went into business tie-up with Idemitsu Kosan in the area of livestock.  Domestic clients include pharmaceuticals mfrs, wholesalers, other.

 

FINANCIAL information

 

Finance partially disclosed

 

The sales volume for May/2014 fiscal term amounted to Yen 36,455 million, a 4% up from Yen 35,002 million in the previous term.  The recurring profit was posted at Yen 3,674 million and the net profit at Yen 2,222 million, respectively, compared with Yen 4,858 million recurring profit and Yen 3,443 million net profit, respectively, a year ago.

 For the term that ending May 2015 the net profit at Yen 2,266 million is estimated based on a 2% rise in turnover, to Yen 37,184 million.  Final results are yet to be released.

The financial situation is considered FAIR and good for ORDINARY business engagements.  Max credit limit is estimated at Yen 216.9 million, on 30 days normal terms.


 

THE FINANCIALS

Note: Forecast (or estimated) figures for the 31/05/2015 fiscal term

Terms Ending:

31/05/2015

31/05/2014

31/05/2013

31/05/2012

Annual Sales

37,184

36,455

35,002

32,754

Recur. Profit

 

3,674

4,858

3,397

Net Profit

2,266

2,222

3,443

2,201

Total Assets

 

 

 

27,975

Net Worth

 

 

 

20,230

Capital, Paid-Up

 

 

 

55

Div.P.Share(¥)

 

0.00

0.00

1,000.00

<Analytical Data>

(%)

(%)

(%)

(%)

       S.Growth Rate

2.00

4.15

6.86

 

       Current Ratio

 

..

..

..

       N.Worth Ratio

 

..

..

72.31

       N.Profit/Sales

6.10

6.10

9.84

6.72

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.93.19

UK Pound

1

Rs.94.94

Euro

1

Rs.67.56

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

ASH

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.